- Home
- DRH vs TVTX Comparison
DRH vs TVTX Comparison
Compare DRH & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRH
- TVTX
- Stock Information
- Founded
- DRH 2004
- TVTX 2008
- Country
- DRH United States
- TVTX United States
- Employees
- DRH N/A
- TVTX N/A
- Industry
- DRH Real Estate Investment Trusts
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DRH Real Estate
- TVTX Health Care
- Exchange
- DRH Nasdaq
- TVTX Nasdaq
- Market Cap
- DRH 1.7B
- TVTX 1.9B
- IPO Year
- DRH 2005
- TVTX N/A
- Fundamental
- Price
- DRH $7.65
- TVTX $19.68
- Analyst Decision
- DRH Hold
- TVTX Strong Buy
- Analyst Count
- DRH 5
- TVTX 13
- Target Price
- DRH $10.05
- TVTX $33.17
- AVG Volume (30 Days)
- DRH 2.8M
- TVTX 1.6M
- Earning Date
- DRH 05-01-2025
- TVTX 05-05-2025
- Dividend Yield
- DRH 4.84%
- TVTX N/A
- EPS Growth
- DRH N/A
- TVTX N/A
- EPS
- DRH 0.18
- TVTX N/A
- Revenue
- DRH $1,129,883,000.00
- TVTX $233,175,000.00
- Revenue This Year
- DRH $2.40
- TVTX $72.95
- Revenue Next Year
- DRH $2.94
- TVTX $53.84
- P/E Ratio
- DRH $42.44
- TVTX N/A
- Revenue Growth
- DRH 5.12
- TVTX 60.55
- 52 Week Low
- DRH $7.54
- TVTX $5.12
- 52 Week High
- DRH $10.00
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- DRH 34.18
- TVTX 45.64
- Support Level
- DRH $7.65
- TVTX $20.29
- Resistance Level
- DRH $8.04
- TVTX $20.98
- Average True Range (ATR)
- DRH 0.22
- TVTX 0.90
- MACD
- DRH -0.01
- TVTX 0.07
- Stochastic Oscillator
- DRH 12.21
- TVTX 54.12
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.